S6K1 is involved in polyploidization through its phosphorylation at Thr421/Ser424

Area of Science:

• Cell Biology
• Hematology
• Molecular Biology

Background:

• Megakaryocyte polyploidization is essential for platelet production but challenging to study due to a lack of synchronized cell models.
• Understanding the molecular mechanisms regulating megakaryocyte ploidy is critical for hematological research.

Purpose of the Study:

• To establish a synchronized polyploid megakaryocyte cell model for studying polyploidization mechanisms.
• To investigate the role of the ribosomal S6 kinase 1 (S6K1)/4E-binding protein 1 (4E-BP1) pathway in megakaryocyte polyploidization.

Main Methods:

• Development of a synchronized polyploid cell model using Dami cells treated with nocodazole.
• Analysis of protein phosphorylation (S6K1, 4E-BP1) and cell cycle regulator expression (cyclins, p21, p27) via Western blotting.
• Manipulation of S6K1 activity through overexpression of kinase-dead or rapamycin-resistant forms.
• Treatment with a novel compound MAP to assess its effect on S6K1 phosphorylation and polyploidization.

Main Results:

• Nocodazole-induced Dami cells exhibited normal cyclin B oscillation and phosphorylation of S6K1 (Thr421/Ser424) and 4E-BP1 in the cytoplasm during M-phase.
• Phorbol 12-myristate 13-acetate (PMA) induced differentiation with decreased S6K1/4E-BP1 phosphorylation and altered cyclin/p21/p27 expression.
• Overexpression of kinase-dead S6K1 increased ploidy, while rapamycin-resistant S6K1 reduced 4E-BP1 phosphorylation, altered cell cycle gene expression, and decreased ploidy.
• The novel compound MAP partially inhibited S6K1 phosphorylation, decreased p27 expression, and reduced polyploidization in nocodazole-treated cells.

Conclusions:

• The S6K1/4E-BP1 signaling pathway plays a significant role in regulating megakaryocyte polyploidization.
• The established nocodazole-induced Dami cell model provides a valuable tool for future studies on megakaryocyte biology and polyploidization.